XML 48 R38.htm IDEA: XBRL DOCUMENT v3.23.1
Collaboration Agreements And Business Development Activities -Royalty Pharma Narrative (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2023
Apr. 01, 2022
Collaboration Agreement with GlaxoSmithKline    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Percent of royalty on net sale 3.00%  
Royal Pharma    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Royalty expense $ 15.4 $ 13.1